Odevixibat by Ipsen for Biliary Atresia: Likelihood of Approval

Odevixibat is under clinical development by Ipsen and currently in Phase III for Biliary Atresia.

Dolbey, SOAP Health Partner on AI-Driven Early Disease Detection

What You Should Know: Dolbey and Company, Inc. has announced a strategic partnership with SOAP Health, a leading AI medical practice innovator. This collaboration brings together Dolbey’s

August 18, 2023

I cried tears of loss and rage at the World Hepatitis Summit

At this year’s World Hepatitis Summit in Lisbon, Portugal, the World Hepatitis Alliance presented me with an award that recognized my leadership as the organization’s

June 16, 2024

Medicare Doc Payment Fix Bill Moving Along, GOP Doctors Caucus Co-Chair Says

Rep. Greg Murphy, MD (R-N.C.), co-chair of the House GOP Doctors Caucus, said on Friday he is hopeful that his bill to reverse the cut

January 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.